top of page

ACCELERATING DRUG DISCOVERY. TODAY.

​

 

​

 

​

​

TRULY QUANTITATIVE 

​

HIGHLY SENSITIVE

​

> BROAD DYNAMIC RANGE

​

Product

OUR TECHNOLOGY

01 / FAST

Biomolex has developed a unique technology that allows for faster image acquisition than conventional technology.

02 / HIGH RESOLUTION

Our radiographic labelling of molecules allows for a higher resolution than conventional molecular imaging.

03 / DISRUPTIVE

Our system aims to transform the drug discovery process, starting with kinase drug targets for oncology. 

Double Sided Silicon Strip

Superior Image Quality and Detail

Competitor Imager

72 hours

Biomolex Imager

72 hours

IMAGE GALLERY

MEET BIOMOLEX

OUR STORY

Biomolex AS is a Norwegian biotech company that was established as a joint venture between The Norwegian Radium Hospital (NRH) and Ideas ASA (Ideas) in May 2001. Biomolex has developed a unique patented microarray reader - an imaging system for gene and protein analysis.

OUR VISION

We provide tools that accelerate drug discovery, enable precision medicine and increase the quality of data in research. Our vision is to become a unique supplier of kinase arrays for diagnostics and drug development.

OUR TECHNOLOGY

The Biomolex digital radiography system provides real time detection of multiple radioisotope labels. With a higher sensitivity than classical phosphorimagers, we aim to make molecular imaging more precise.

MANAGEMENT

Eirik Næss-Ulseth

Chairman of the Board

Håvard Hildeng Hauge

Chief Executive Officer

About

USING BIOMOLEX 700

Featured

3D distribution of labeled antibody; CD20+ tumor (I-131)

 

Imaging provided by UCLA

GET IN TOUCH

Tel:  +47 22 14 70 87   

Fax: +47 22 13 79 11

Klaus Torgårds Vei 3 – 0372

Oslo – Norway

Contact

REQUEST A DEMO

Please fill your contact details below:

Success! Message received.

Demo
bottom of page